NovaSom works with Durable Medical Equipment suppliers (DMEs) to provide home-sleep testing services that deliver improved accuracy and reduced testing variability than conventional polysolmnography (PSG).
As an innovator and pioneer in our field, we developed the first FDA-cleared device designed for unattended, unassisted patient use with clinically proven* equivalence to conventional PSG for the diagnosis of sleep apnea.
*Claman, Murr and Trotter Study
*Reichert, Bloch, Cundiff, and Votteri Study
Our leading-edge technology and simplified engineering make the test easy for patients to administer, a factor that has been shown to improve participation rates. The test is taken over multiple nights, which has been shown to identify more at-risk patients than single night tests, whether administered at home or in a sleep lab.
Working in collaboration with prescribers, NovaSom provides diagnostic services that can improve the health and quality of life of their patients.
